NCT03608319View on ClinicalTrials.gov

Study of A4250 in Healthy Volunteers Under Fasting, Fed and Sprinkled Conditions

PHASE1CompletedINTERVENTIONAL

Enrollment

17

Participants

Timeline

Start Date

July 5, 2018

Primary Completion Date

August 5, 2018

Study Completion Date

August 18, 2018

Conditions

Healthy Volunteers

Interventions

DRUG

A4250

9.6 mg

Trial Locations (1)

68502

Celerion, Lincoln

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Celerion

INDUSTRY

lead

Albireo

INDUSTRY